Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 -24.92M
June 30, 2025 -8.460M
March 31, 2025 -15.18M
December 31, 2024 4.699M
September 30, 2024 -17.95M
June 30, 2024 -3.469M
March 31, 2024 -6.211M
December 31, 2023 9.291M
September 30, 2023 1.819M
June 30, 2023 -0.3021M
March 31, 2023 -3.405M
December 31, 2022 3.323M
September 30, 2022 -17.33M
June 30, 2022 -71.78M
Date Value
March 31, 2022 -27.82M
December 31, 2021 2.432M
September 30, 2021 16.46M
June 30, 2021 -15.92M
March 31, 2021 -3.488M
December 31, 2020 -15.00M
September 30, 2020 -6.884M
June 30, 2020 -17.98M
March 31, 2020 -10.43M
December 31, 2019 -5.999M
September 30, 2019 -11.32M
June 30, 2019 -41.96M
March 31, 2019 -0.2039M
December 31, 2018 0.9049M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. -0.4422M
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. 56.67M
Corcept Therapeutics, Inc. 33.54M

Cash from Operations (Quarterly) Related Metrics